首页 > 最新文献

Visceral Medicine最新文献

英文 中文
Incidence, Diagnosis, and Management of Proctological Conditions during Pregnancy. 妊娠期直肠疾病的发生率、诊断和管理。
IF 1.6 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-06-27 DOI: 10.1159/000545793
Rosa Bianca Schmuck, Michael Roblick

Background: Proctological diseases are highly prevalent during pregnancy, with reported incidence rates ranging from 45% to 68%. The true prevalence is likely higher due to underreporting. These conditions frequently persist into the postpartum period, causing significant discomfort and emotional distress. Physiological changes in the maternal body - including hormonal, metabolic, immunological, and cardiovascular alterations - play a central role in the development of these disorders. The enlargement of the uterus, increased blood volume, and elevated pressure in the pelvic veins contribute to venous stasis in the hemorrhoidal plexus, thereby predisposing pregnant individuals to symptomatic hemorrhoids and perianal thromboses.

Summary: The most frequently reported symptoms are anal pain and constipation. Anal pain, which is often intense, is commonly associated with constipation and is due to the high density of sensory nerve endings in the anal canal. Constipation affects more than 60% of pregnant women, primarily as a result of hormonal changes, decreased physical activity, and iron supplementation. Straining during defecation further aggravates proctological conditions, facilitating the development of hemorrhoids, anal fissures, and perianal thrombosis. Diagnosis should include a thorough medical history, physical examination, and proctoscopy. In selected cases, additional imaging may be warranted. Conservative treatment is the mainstay of management, with a focus on symptom control and regulation of bowel habits. Hemorrhoidal disease is particularly common during pregnancy. Conservative treatment includes increased fluid intake, the use of stool softeners, and local cooling measures. Surgical interventions should be reserved for refractory cases and only considered when absolutely necessary. Anal fissures, the second most prevalent condition after hemorrhoids, are primarily caused by constipation. First-line treatment involves stool regulation, analgesic therapy, and the application of topical ointments. While chronic fissures may occasionally require surgical intervention, noninvasive approaches are strongly preferred to minimize risks. Perianal thrombosis, often misdiagnosed as thrombosed external hemorrhoids, typically occurs in the third trimester or shortly after delivery. Conservative therapy is generally effective, focusing on pain control. In selected cases, surgical excision of thrombosed nodules may be indicated.

Key messages: In summary, proctological conditions during pregnancy are common but usually manageable through accurate diagnosis, conservative treatment, and empathetic patient support. Prioritizing symptom relief and avoiding unnecessary surgical interventions are essential to achieving favorable outcomes.

背景:直肠疾病在怀孕期间非常普遍,据报道发病率从45%到68%不等。由于漏报,真实患病率可能更高。这些情况经常持续到产后,造成明显的不适和情绪困扰。母体的生理变化——包括激素、代谢、免疫和心血管的改变——在这些疾病的发展中起着核心作用。子宫增大、血容量增加和盆腔静脉压力升高导致痔疮丛静脉淤积,从而使孕妇容易出现症状性痔疮和肛周血栓形成。总结:最常见的症状是肛门疼痛和便秘。肛门疼痛,通常是强烈的,通常与便秘有关,是由于肛管中感觉神经末梢的高密度。便秘影响超过60%的孕妇,主要是由于荷尔蒙变化、体力活动减少和铁补充剂。排便时紧张会进一步加重直肠疾病,促进痔疮、肛裂和肛周血栓形成。诊断应包括全面的病史、体格检查和直肠镜检查。在某些情况下,可能需要进行额外的影像学检查。保守治疗是治疗的支柱,重点是症状控制和排便习惯的调节。痔疮病在怀孕期间尤为常见。保守治疗包括增加液体摄入、使用大便软化剂和局部降温措施。手术干预应保留在难治性病例,只有在绝对必要时才考虑。肛裂是仅次于痔疮的第二大常见疾病,主要由便秘引起。一线治疗包括排便调节、镇痛治疗和局部软膏的应用。虽然慢性骨折偶尔需要手术干预,但非侵入性方法是最大限度地降低风险的首选方法。肛周血栓形成常被误诊为血栓性外痔,通常发生在妊娠晚期或分娩后不久。保守疗法通常是有效的,重点是控制疼痛。在选定的病例中,可能需要手术切除血栓形成的结节。总之,妊娠期直肠疾病是常见的,但通常可以通过准确的诊断、保守治疗和同情患者的支持来控制。优先缓解症状和避免不必要的手术干预是获得良好结果的必要条件。
{"title":"Incidence, Diagnosis, and Management of Proctological Conditions during Pregnancy.","authors":"Rosa Bianca Schmuck, Michael Roblick","doi":"10.1159/000545793","DOIUrl":"10.1159/000545793","url":null,"abstract":"<p><strong>Background: </strong>Proctological diseases are highly prevalent during pregnancy, with reported incidence rates ranging from 45% to 68%. The true prevalence is likely higher due to underreporting. These conditions frequently persist into the postpartum period, causing significant discomfort and emotional distress. Physiological changes in the maternal body - including hormonal, metabolic, immunological, and cardiovascular alterations - play a central role in the development of these disorders. The enlargement of the uterus, increased blood volume, and elevated pressure in the pelvic veins contribute to venous stasis in the hemorrhoidal plexus, thereby predisposing pregnant individuals to symptomatic hemorrhoids and perianal thromboses.</p><p><strong>Summary: </strong>The most frequently reported symptoms are anal pain and constipation. Anal pain, which is often intense, is commonly associated with constipation and is due to the high density of sensory nerve endings in the anal canal. Constipation affects more than 60% of pregnant women, primarily as a result of hormonal changes, decreased physical activity, and iron supplementation. Straining during defecation further aggravates proctological conditions, facilitating the development of hemorrhoids, anal fissures, and perianal thrombosis. Diagnosis should include a thorough medical history, physical examination, and proctoscopy. In selected cases, additional imaging may be warranted. Conservative treatment is the mainstay of management, with a focus on symptom control and regulation of bowel habits. Hemorrhoidal disease is particularly common during pregnancy. Conservative treatment includes increased fluid intake, the use of stool softeners, and local cooling measures. Surgical interventions should be reserved for refractory cases and only considered when absolutely necessary. Anal fissures, the second most prevalent condition after hemorrhoids, are primarily caused by constipation. First-line treatment involves stool regulation, analgesic therapy, and the application of topical ointments. While chronic fissures may occasionally require surgical intervention, noninvasive approaches are strongly preferred to minimize risks. Perianal thrombosis, often misdiagnosed as thrombosed external hemorrhoids, typically occurs in the third trimester or shortly after delivery. Conservative therapy is generally effective, focusing on pain control. In selected cases, surgical excision of thrombosed nodules may be indicated.</p><p><strong>Key messages: </strong>In summary, proctological conditions during pregnancy are common but usually manageable through accurate diagnosis, conservative treatment, and empathetic patient support. Prioritizing symptom relief and avoiding unnecessary surgical interventions are essential to achieving favorable outcomes.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503519/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145253700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Management of Postsurgical Complications. 术后并发症的内镜处理。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-06-23 DOI: 10.1159/000546895
Jörn Bernhardt, Mark Ellrichmann
{"title":"Endoscopic Management of Postsurgical Complications.","authors":"Jörn Bernhardt, Mark Ellrichmann","doi":"10.1159/000546895","DOIUrl":"10.1159/000546895","url":null,"abstract":"","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12215439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144562096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Histomorphological Features for the Prediction of Grade C Fistula after Whipple Procedure: A Difficult Task. 使用组织形态学特征预测惠普尔手术后C级瘘:一项艰巨的任务。
IF 1.6 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-06-01 Epub Date: 2025-01-08 DOI: 10.1159/000543436
Tim Fahlbusch, Georgios Antoniou, Philipp Höhn, Andrea Tannapfel, Waldemar Uhl, Orlin Belyaev, Johanna Munding

Introduction: The prediction of occurrence and form of a postoperative pancreatic fistula (POPF) could decrease the risk after pancreatic resections. We developed a score based on histomorphological criteria to predict POPF earlier on. In this study, we test the scoring system to differentiate between patients developing grades B and C POPF.

Methods: We analysed 92 patients who underwent pancreatic head resection and developed a grade B or C POPF postoperatively. There were no exclusion criteria. Pancreatic resection margins were analysed histologically and pancreatic duct size, fibrosis, fat content, and signs of inflammation were transformed into a scoring system.

Results: Patients with a grade B fistula (n = 48) were compared to patients with grade C fistula (n = 44). The grade C group was characterized by higher mortality (0 vs. 22, p < 0.001), postpancreatectomy haemorrhage (3 vs. 24, p < 0.001), longer stays in intensive care unit (2.6 vs. 21.1, p < 0.001) and in hospital (29.8 vs. 44.6, p < 0.001). The scoring system was unable to predict grade C fistula. We calculated receiver operator characteristics for all assessed characteristics, which revealed an area under the curve of 0.561. The strongest predictors of POPF grade C were pancreatic fat and soft pancreatic tissue. A combination of only these two items led to a statistically significant difference (p < 0.001) and an AUC of 0.771.

Conclusion: Establishing a score to differentiate between grade B and grade C POPF is a difficult task. Pancreatic fat seems to be the most relevant histomorphological feature to be used in any scoring system, and it should be combined with other clinical features to enhance its precision and validity.

前言:预测术后胰瘘(POPF)的发生和形成可以降低胰腺切除术后的风险。我们开发了一个基于组织形态学标准的评分来预测早期的POPF。在这项研究中,我们测试了评分系统来区分B级和C级POPF患者。方法:我们分析了92例胰头切除术后发生B级或C级POPF的患者。没有排除标准。对胰腺切除边缘进行组织学分析,并将胰管大小、纤维化、脂肪含量和炎症迹象转化为评分系统。结果:B级瘘管患者(n = 48)与C级瘘管患者(n = 44)进行了比较。C级组的特点是死亡率更高(0比22,p < 0.001),胰腺切除术后出血(3比24,p < 0.001),在重症监护病房的住院时间更长(2.6比21.1,p < 0.001)和住院时间更长(29.8比44.6,p < 0.001)。评分系统无法预测C级瘘管。我们计算了所有评估特征的接收算子特征,结果显示曲线下面积为0.561。胰腺脂肪和胰腺软组织是POPF C级的最强预测因子。仅这两个项目的组合导致统计学显著差异(p < 0.001), AUC为0.771。结论:建立一个评分来区分B级和C级POPF是一项困难的任务。胰腺脂肪似乎是任何评分系统中最相关的组织形态学特征,应与其他临床特征相结合,以提高其准确性和有效性。
{"title":"Use of Histomorphological Features for the Prediction of Grade C Fistula after Whipple Procedure: A Difficult Task.","authors":"Tim Fahlbusch, Georgios Antoniou, Philipp Höhn, Andrea Tannapfel, Waldemar Uhl, Orlin Belyaev, Johanna Munding","doi":"10.1159/000543436","DOIUrl":"10.1159/000543436","url":null,"abstract":"<p><strong>Introduction: </strong>The prediction of occurrence and form of a postoperative pancreatic fistula (POPF) could decrease the risk after pancreatic resections. We developed a score based on histomorphological criteria to predict POPF earlier on. In this study, we test the scoring system to differentiate between patients developing grades B and C POPF.</p><p><strong>Methods: </strong>We analysed 92 patients who underwent pancreatic head resection and developed a grade B or C POPF postoperatively. There were no exclusion criteria. Pancreatic resection margins were analysed histologically and pancreatic duct size, fibrosis, fat content, and signs of inflammation were transformed into a scoring system.</p><p><strong>Results: </strong>Patients with a grade B fistula (<i>n</i> = 48) were compared to patients with grade C fistula (<i>n</i> = 44). The grade C group was characterized by higher mortality (0 vs. 22, <i>p</i> < 0.001), postpancreatectomy haemorrhage (3 vs. 24, <i>p</i> < 0.001), longer stays in intensive care unit (2.6 vs. 21.1, <i>p</i> < 0.001) and in hospital (29.8 vs. 44.6, <i>p</i> < 0.001). The scoring system was unable to predict grade C fistula. We calculated receiver operator characteristics for all assessed characteristics, which revealed an area under the curve of 0.561. The strongest predictors of POPF grade C were pancreatic fat and soft pancreatic tissue. A combination of only these two items led to a statistically significant difference (<i>p</i> < 0.001) and an AUC of 0.771.</p><p><strong>Conclusion: </strong>Establishing a score to differentiate between grade B and grade C POPF is a difficult task. Pancreatic fat seems to be the most relevant histomorphological feature to be used in any scoring system, and it should be combined with other clinical features to enhance its precision and validity.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":"41 3","pages":"110-120"},"PeriodicalIF":1.6,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12165639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144303714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Endoflip - Impedance Planimetry System: For Which Indications? 内翻转-阻抗平面测量系统的使用:用于哪些适应症?
IF 1.6 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-06-01 Epub Date: 2025-01-07 DOI: 10.1159/000542545
Sandra Nagl, Alanna Ebigbo, Helmut Messmann

Background: The functional lumen imaging probe (EndoFLIP), which utilizes impedance planimetry, has emerged as a valuable tool for a more comprehensive evaluation of esophageal physiology and pathophysiology beyond traditional high-resolution manometry.

Summary: EndoFLIP, including its variations EndoFLIP and EsoFLIP, measures intraluminal distensibility and compliance by assessing diameter and distension pressure using balloon catheters.

Key messages: This technology is applicable to various organs such as the esophagus, stomach, and anorectal region, and serves in both diagnostic and therapeutic contexts, especially in ambiguous clinical cases.

背景:利用阻抗平面测量技术的功能性管腔成像探针(EndoFLIP)已经成为一种有价值的工具,可以比传统的高分辨率测压法更全面地评估食管生理和病理生理。EndoFLIP,包括其变体EndoFLIP和EsoFLIP,通过使用球囊导管评估直径和扩张压力来测量腔内扩张性和顺应性。关键信息:该技术适用于食道、胃、肛肠等多种器官,可用于诊断和治疗,特别是在临床上模棱两可的情况下。
{"title":"Use of Endoflip - Impedance Planimetry System: For Which Indications?","authors":"Sandra Nagl, Alanna Ebigbo, Helmut Messmann","doi":"10.1159/000542545","DOIUrl":"10.1159/000542545","url":null,"abstract":"<p><strong>Background: </strong>The functional lumen imaging probe (EndoFLIP), which utilizes impedance planimetry, has emerged as a valuable tool for a more comprehensive evaluation of esophageal physiology and pathophysiology beyond traditional high-resolution manometry.</p><p><strong>Summary: </strong>EndoFLIP, including its variations EndoFLIP and EsoFLIP, measures intraluminal distensibility and compliance by assessing diameter and distension pressure using balloon catheters.</p><p><strong>Key messages: </strong>This technology is applicable to various organs such as the esophagus, stomach, and anorectal region, and serves in both diagnostic and therapeutic contexts, especially in ambiguous clinical cases.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":"41 3","pages":"137-146"},"PeriodicalIF":1.6,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12165644/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144303713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomarkers for Early Detection of Pancreatic Cancer. 早期发现胰腺癌的生物标志物。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-28 DOI: 10.1159/000546584
Axel Bengtsson, Roland Andersson, Johan Linders, Aiste Gulla, Daniel Ansari

Background: Pancreatic cancer continues to retain the highest mortality rate among all major organ cancers. New strategies for early detection are being proposed to increase long-term survival. A plethora of molecular markers are discovered yearly, but so far none have demonstrated screening utility.

Summary: Promising discovery technologies include affinity-based proteomics and ddPCR. In the validation phase, researchers must decide on key benchmark criteria, what type of pancreatic lesions are desirable to find early through molecular screening, and when to terminate the biomarker study and return to the discovery phase. If the biomarkers meet set benchmarks, retrospective analysis should be conducted in relevant cohorts based on intended use, followed by prospective real-world evaluation. Lastly, regulatory approval, incorporation into clinical practice guidelines, and thorough health economic evaluations must be completed before the screening markers can be fully implemented.

Key messages: In this review, important strategies and phases for molecular biomarker development in pancreatic cancer have been outlined.

背景:胰腺癌仍然是所有主要器官癌症中死亡率最高的。正在提出早期发现的新策略,以提高长期生存率。每年都有大量的分子标记被发现,但到目前为止还没有一个显示出筛查的效用。摘要:基于亲和的蛋白质组学和ddPCR是有前途的发现技术。在验证阶段,研究人员必须确定关键的基准标准,通过分子筛选早期发现哪种类型的胰腺病变,以及何时终止生物标志物研究并返回发现阶段。如果生物标志物符合设定的基准,则应根据预期用途在相关队列中进行回顾性分析,然后进行前瞻性实际评估。最后,在全面实施筛查标志物之前,必须完成监管部门的批准、纳入临床实践指南和全面的健康经济评估。本文综述了胰腺癌分子生物标志物开发的重要策略和阶段。
{"title":"Biomarkers for Early Detection of Pancreatic Cancer.","authors":"Axel Bengtsson, Roland Andersson, Johan Linders, Aiste Gulla, Daniel Ansari","doi":"10.1159/000546584","DOIUrl":"10.1159/000546584","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic cancer continues to retain the highest mortality rate among all major organ cancers. New strategies for early detection are being proposed to increase long-term survival. A plethora of molecular markers are discovered yearly, but so far none have demonstrated screening utility.</p><p><strong>Summary: </strong>Promising discovery technologies include affinity-based proteomics and ddPCR. In the validation phase, researchers must decide on key benchmark criteria, what type of pancreatic lesions are desirable to find early through molecular screening, and when to terminate the biomarker study and return to the discovery phase. If the biomarkers meet set benchmarks, retrospective analysis should be conducted in relevant cohorts based on intended use, followed by prospective real-world evaluation. Lastly, regulatory approval, incorporation into clinical practice guidelines, and thorough health economic evaluations must be completed before the screening markers can be fully implemented.</p><p><strong>Key messages: </strong>In this review, important strategies and phases for molecular biomarker development in pancreatic cancer have been outlined.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12215441/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144562095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence-Augmented Imaging for Early Pancreatic Cancer Detection. 人工智能增强成像用于早期胰腺癌检测。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-28 DOI: 10.1159/000546603
Ajith Antony, Sovanlal Mukherjee, Khurram Bhinder, Murlidhar Murlidhar, Armin Zarrintan, Ajit H Goenka

Background: Pancreatic ductal adenocarcinoma (PDA) is a highly lethal malignancy, often diagnosed at an advanced stage due to its insidious progression and the absence of effective early detection strategies. Accurate diagnosis and staging are critical for optimizing treatment selection and improving patient survival. Contrast-enhanced computed tomography (CT) remains the diagnostic standard for PDA; however, its sensitivity is limited by interobserver variability and the frequent absence of overt morphological abnormalities in early stage disease.

Summary: Artificial intelligence (AI) has emerged as a promising tool for overcoming the inherent limitations of conventional radiologic assessment by leveraging radiomics and deep learning models to extract subtle imaging signatures of PDA that are imperceptible to the human eye. AI-driven models have demonstrated the ability to detect pre-diagnostic PDA on CT scans months to years before clinical presentation by identifying textural and structural changes in the pancreas. Furthermore, automated volumetric pancreas segmentation enhances reproducibility and facilitates the discovery of imaging biomarkers associated with early carcinogenesis. Despite these advances, key challenges remain, including dataset heterogeneity, model interpretability, and prospective validation in real-world clinical settings.

Key messages: AI-driven approaches offer a transformative opportunity to augment CT-based PDA detection, reduce diagnostic uncertainty, and facilitate earlier intervention. However, robust external validation, integration into clinical workflows, and prospective trials are essential to establish AI as a reliable adjunct in PDA diagnosis and staging.

背景:胰腺导管腺癌(PDA)是一种高度致命的恶性肿瘤,由于其隐匿的进展和缺乏有效的早期发现策略,通常在晚期诊断。准确的诊断和分期是优化治疗选择和提高患者生存率的关键。对比增强计算机断层扫描(CT)仍然是PDA的诊断标准;然而,它的敏感性受到观察者之间的可变性和在早期疾病中经常没有明显的形态异常的限制。摘要:人工智能(AI)已经成为克服传统放射学评估固有局限性的一种有前途的工具,它利用放射组学和深度学习模型来提取人眼无法察觉的PDA细微成像特征。人工智能驱动的模型已经证明,通过识别胰腺的结构和结构变化,能够在临床表现前数月至数年在CT扫描中发现预诊断的PDA。此外,自动胰腺体积分割提高了可重复性,并有助于发现与早期癌变相关的成像生物标志物。尽管取得了这些进展,但仍存在一些关键挑战,包括数据集的异质性、模型的可解释性以及在现实世界临床环境中的前瞻性验证。关键信息:人工智能驱动的方法提供了一个变革性的机会,增强了基于ct的PDA检测,减少了诊断的不确定性,并促进了早期干预。然而,强大的外部验证、整合到临床工作流程和前瞻性试验对于将人工智能作为PDA诊断和分期的可靠辅助手段至关重要。
{"title":"Artificial Intelligence-Augmented Imaging for Early Pancreatic Cancer Detection.","authors":"Ajith Antony, Sovanlal Mukherjee, Khurram Bhinder, Murlidhar Murlidhar, Armin Zarrintan, Ajit H Goenka","doi":"10.1159/000546603","DOIUrl":"10.1159/000546603","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic ductal adenocarcinoma (PDA) is a highly lethal malignancy, often diagnosed at an advanced stage due to its insidious progression and the absence of effective early detection strategies. Accurate diagnosis and staging are critical for optimizing treatment selection and improving patient survival. Contrast-enhanced computed tomography (CT) remains the diagnostic standard for PDA; however, its sensitivity is limited by interobserver variability and the frequent absence of overt morphological abnormalities in early stage disease.</p><p><strong>Summary: </strong>Artificial intelligence (AI) has emerged as a promising tool for overcoming the inherent limitations of conventional radiologic assessment by leveraging radiomics and deep learning models to extract subtle imaging signatures of PDA that are imperceptible to the human eye. AI-driven models have demonstrated the ability to detect pre-diagnostic PDA on CT scans months to years before clinical presentation by identifying textural and structural changes in the pancreas. Furthermore, automated volumetric pancreas segmentation enhances reproducibility and facilitates the discovery of imaging biomarkers associated with early carcinogenesis. Despite these advances, key challenges remain, including dataset heterogeneity, model interpretability, and prospective validation in real-world clinical settings.</p><p><strong>Key messages: </strong>AI-driven approaches offer a transformative opportunity to augment CT-based PDA detection, reduce diagnostic uncertainty, and facilitate earlier intervention. However, robust external validation, integration into clinical workflows, and prospective trials are essential to establish AI as a reliable adjunct in PDA diagnosis and staging.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-9"},"PeriodicalIF":1.8,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12187166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144499483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Intervention in Pediatric Endoscopy: Management of Postsurgical Complications and Bleeding. 儿童内窥镜检查的治疗干预:术后并发症和出血的处理。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-24 DOI: 10.1159/000545893
André Hoerning, Guido Seitz, Dominique Schluckebier, Jan de Laffolie

Background: Pediatric surgical complications and their endoscopic treatment approaches share a unique challenge of small anatomy, highly volatile situations and the need to be flexible with instruments which have been designed for older and bigger patients. In the last few decades, endoscopic interventions have emerged as a minimally invasive alternative approach to standard open closure procedures for the treatment of postsurgical complications.

Summary: This review summarizes the most common situations and techniques in pediatric endoscopy taking on postsurgical complications, including opportunities to improve outcome and overcome barriers of individualized therapy as compared to adult strategies.

Key message: Endoscopic management of postsurgical complications is highly effective and associated with high success rates, low mortality, and minimal recurrence of the underlying pathology.

背景:小儿外科并发症及其内窥镜治疗方法面临着独特的挑战,解剖结构小,情况高度不稳定,需要灵活使用为年龄较大和体型较大的患者设计的器械。在过去的几十年里,内窥镜干预已经成为治疗术后并发症的标准开合手术的一种微创替代方法。摘要:本综述总结了儿科内镜治疗术后并发症的最常见情况和技术,包括与成人策略相比,改善结果和克服个性化治疗障碍的机会。关键信息:内镜下处理术后并发症是非常有效的,具有高成功率、低死亡率和最小的基础病理复发率。
{"title":"Therapeutic Intervention in Pediatric Endoscopy: Management of Postsurgical Complications and Bleeding.","authors":"André Hoerning, Guido Seitz, Dominique Schluckebier, Jan de Laffolie","doi":"10.1159/000545893","DOIUrl":"10.1159/000545893","url":null,"abstract":"<p><strong>Background: </strong>Pediatric surgical complications and their endoscopic treatment approaches share a unique challenge of small anatomy, highly volatile situations and the need to be flexible with instruments which have been designed for older and bigger patients. In the last few decades, endoscopic interventions have emerged as a minimally invasive alternative approach to standard open closure procedures for the treatment of postsurgical complications.</p><p><strong>Summary: </strong>This review summarizes the most common situations and techniques in pediatric endoscopy taking on postsurgical complications, including opportunities to improve outcome and overcome barriers of individualized therapy as compared to adult strategies.</p><p><strong>Key message: </strong>Endoscopic management of postsurgical complications is highly effective and associated with high success rates, low mortality, and minimal recurrence of the underlying pathology.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12215443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144562097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgery of Early-Stage Pancreatic Cancer. 早期胰腺癌的外科手术。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-15 DOI: 10.1159/000546416
Jelte Poppinga, Alina S Ritter, Kira C Steinkraus, Anna Nießen, Thilo Hackert

Background: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, with early detection and surgical resection being the only potentially curative treatment option. Despite advancements in diagnostics and surgical techniques, the prognosis of early-stage PDAC remains poor. Understanding the indications, approaches and perioperative management are crucial for improving patient survival.

Summary: Surgical resection remains the only curative treatment for early-stage PDAC. Different surgical procedures are performed depending on tumor location and local extent. Advances in minimally invasive surgery (MIS) yielded promising results regarding postoperative recovery and oncologic outcomes. The implementation of neoadjuvant therapy has improved resection and survival rates. Still, pancreatic surgery is associated with significant morbidity.

Key messages: Surgical resection remains the only curative option for early-stage pancreatic cancer. Neoadjuvant chemotherapy plays a crucial role in improving resection and survival rates. Perioperative care has been refined by MIS, optimized surgical techniques, and structured complication management.

背景:胰腺导管腺癌(PDAC)仍然是最致命的恶性肿瘤之一,早期发现和手术切除是唯一可能治愈的治疗选择。尽管诊断和手术技术的进步,早期PDAC的预后仍然很差。了解适应证、入路和围手术期管理对提高患者生存率至关重要。总结:手术切除仍然是治疗早期PDAC的唯一方法。根据肿瘤的位置和局部范围,采取不同的手术方法。微创手术(MIS)的进步在术后恢复和肿瘤预后方面取得了可喜的结果。新辅助治疗的实施提高了切除率和生存率。尽管如此,胰腺手术仍与显著的发病率相关。关键信息:手术切除仍然是早期胰腺癌的唯一治疗选择。新辅助化疗对提高肿瘤的切除率和生存率起着至关重要的作用。围手术期护理已通过MIS、优化的手术技术和结构化的并发症管理得到完善。
{"title":"Surgery of Early-Stage Pancreatic Cancer.","authors":"Jelte Poppinga, Alina S Ritter, Kira C Steinkraus, Anna Nießen, Thilo Hackert","doi":"10.1159/000546416","DOIUrl":"10.1159/000546416","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, with early detection and surgical resection being the only potentially curative treatment option. Despite advancements in diagnostics and surgical techniques, the prognosis of early-stage PDAC remains poor. Understanding the indications, approaches and perioperative management are crucial for improving patient survival.</p><p><strong>Summary: </strong>Surgical resection remains the only curative treatment for early-stage PDAC. Different surgical procedures are performed depending on tumor location and local extent. Advances in minimally invasive surgery (MIS) yielded promising results regarding postoperative recovery and oncologic outcomes. The implementation of neoadjuvant therapy has improved resection and survival rates. Still, pancreatic surgery is associated with significant morbidity.</p><p><strong>Key messages: </strong>Surgical resection remains the only curative option for early-stage pancreatic cancer. Neoadjuvant chemotherapy plays a crucial role in improving resection and survival rates. Perioperative care has been refined by MIS, optimized surgical techniques, and structured complication management.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-7"},"PeriodicalIF":1.8,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12185108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144487238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Computed Tomography Texture Analysis of Lymph Nodes for Improved Staging Accuracy in Patients with Colon Cancer. 淋巴结的ct纹理分析提高结肠癌患者分期准确性。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-14 DOI: 10.1159/000546336
Jakob Leonhardi, Matthias Mehdorn, Sigmar Stelzner, Uwe Scheuermann, Anne-Kathrin Höhn, Daniel Seehofer, Timm Denecke, Hans-Jonas Meyer

Introduction: Texture analysis can provide quantitative imaging markers and better characterize tumor tissue in oncological imaging. The present analysis investigated the diagnostic benefit of computed tomography (CT)-derived texture analysis to categorize and stage lymph nodes in patients with colon cancer.

Methods: In this study, 85 patients were included (n = 39 females, 45.9%) with a mean age of 70.3 ± 14.8 years. All patients were surgically resected, and the lymph nodes were histopathologically analyzed. All investigated lymph nodes were further investigated with texture analysis using the MaZda package.

Results: Out of a total of 279 extracted CT texture features, 7 parameters independently showed statistically significant differences between lymph node positive to negative ones. For instance, the texture parameter S(1,0)AngScMom showed statistically significant differences regarding lymph node metastasis status (0.007 ± 0.004 for N0 vs. 0.005 ± 0.001 for N1-2, p = 0.001). A multivariate model was developed based on n = 7 independent texture parameters. The diagnostic accuracy reached an area under the curve of 0.79 (95% CI: 0.69-0.89) with a sensitivity of 0.77 and a specificity of 0.70, resulting in an accuracy of 0.73.

Discussion: Texture analysis can improve the diagnostic accuracy for nodal CT staging in patients with colon cancer. Further validation studies are needed to confirm the present results.

在肿瘤成像中,纹理分析可以提供定量的成像标记,更好地表征肿瘤组织。本分析探讨了计算机断层扫描(CT)衍生的纹理分析对结肠癌患者淋巴结的分类和分期的诊断价值。方法:85例患者(女性39例,占45.9%),平均年龄70.3±14.8岁。所有患者均行手术切除,并对淋巴结进行组织病理学分析。所有被调查的淋巴结进一步调查纹理分析使用马自达包。结果:在提取的279个CT纹理特征中,有7个参数在淋巴结阳性与阴性之间独立存在统计学差异。例如,纹理参数S(1,0)AngScMom在淋巴结转移状态方面存在统计学差异(N0为0.007±0.004,N1-2为0.005±0.001,p = 0.001)。基于n = 7个独立纹理参数建立多元模型。诊断准确度达到曲线下面积0.79 (95% CI: 0.69-0.89),敏感性0.77,特异性0.70,准确度0.73。讨论:纹理分析可提高结肠癌患者淋巴结CT分期的诊断准确性。需要进一步的验证研究来证实目前的结果。
{"title":"Computed Tomography Texture Analysis of Lymph Nodes for Improved Staging Accuracy in Patients with Colon Cancer.","authors":"Jakob Leonhardi, Matthias Mehdorn, Sigmar Stelzner, Uwe Scheuermann, Anne-Kathrin Höhn, Daniel Seehofer, Timm Denecke, Hans-Jonas Meyer","doi":"10.1159/000546336","DOIUrl":"10.1159/000546336","url":null,"abstract":"<p><strong>Introduction: </strong>Texture analysis can provide quantitative imaging markers and better characterize tumor tissue in oncological imaging. The present analysis investigated the diagnostic benefit of computed tomography (CT)-derived texture analysis to categorize and stage lymph nodes in patients with colon cancer.</p><p><strong>Methods: </strong>In this study, 85 patients were included (<i>n</i> = 39 females, 45.9%) with a mean age of 70.3 ± 14.8 years. All patients were surgically resected, and the lymph nodes were histopathologically analyzed. All investigated lymph nodes were further investigated with texture analysis using the MaZda package.</p><p><strong>Results: </strong>Out of a total of 279 extracted CT texture features, 7 parameters independently showed statistically significant differences between lymph node positive to negative ones. For instance, the texture parameter S(1,0)AngScMom showed statistically significant differences regarding lymph node metastasis status (0.007 ± 0.004 for N0 vs. 0.005 ± 0.001 for N1-2, <i>p</i> = 0.001). A multivariate model was developed based on <i>n</i> = 7 independent texture parameters. The diagnostic accuracy reached an area under the curve of 0.79 (95% CI: 0.69-0.89) with a sensitivity of 0.77 and a specificity of 0.70, resulting in an accuracy of 0.73.</p><p><strong>Discussion: </strong>Texture analysis can improve the diagnostic accuracy for nodal CT staging in patients with colon cancer. Further validation studies are needed to confirm the present results.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-8"},"PeriodicalIF":1.8,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12187164/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144499484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Management of Postsurgical Complications after Metabolic and Bariatric Surgery. 代谢和减肥手术后并发症的内镜处理。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-08 DOI: 10.1159/000546193
Christine Stier, Sebastian Belle, Patrick Téoule

Background: Following metabolic and bariatric surgery (MBS), a wide range of symptoms may indicate postoperative complications, all of which can prompt endoscopic inspection and multidisciplinary management of potential complications. Therefore, an anatomical and technical understanding of the previous surgical procedure and its forms of reconstruction especially after MBS is crucial for the attending endoscopist to optimize endoluminal therapy. A selective literature review has been performed. This overview of endoscopic complication management aims to outline the available options after MBS.

Summary: Postoperative complication rates vary widely depending on the antecedent procedure and have been reported to be relevant after specific procedures such as laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass in the context of MBS. There is a timeline of 30 days in the postoperative course that divides early from late complications. While anastomotic leaks or endoluminal bleeding are considered typical early complications, late complications include problems such as strictures and anastomotic ulcers. Management of complications in the immediate postoperative period (very early complications) may require a multidisciplinary approach to optimize the outcome of complication management, involving the surgeon, the endoscopist and the ward physician who manages the patient round-the-clock. This hand-in-hand approach enables the best possible treatment for the patient, with endoscopy playing a crucial role in solving endoluminal problems in a much less invasive way than repeated surgical intervention, thereby contributing significantly to an easier postoperative course.

Key messages: The surgical approach, in cooperation with endoluminal complication management, constitutes comprehensive visceral medicine, as endoscopy is the helping hand of surgery in the context of MBS.

背景:代谢和减肥手术(MBS)后,广泛的症状可能提示术后并发症,所有这些都可以提示内镜检查和潜在并发症的多学科管理。因此,对以往的外科手术及其重建形式的解剖学和技术理解,特别是在MBS后,对于主治内镜医师优化腔内治疗至关重要。进行了选择性的文献综述。本内镜并发症管理概述旨在概述MBS后可用的选择。摘要:术后并发症的发生率因术前手术的不同而有很大差异,据报道,在MBS背景下,腹腔镜袖胃切除术或Roux-en-Y胃旁路术等特定手术后并发症发生率也有相关性。术后有一个30天的时间线来区分早期和晚期并发症。虽然吻合口瘘或腔内出血被认为是典型的早期并发症,但晚期并发症包括狭窄和吻合口溃疡等问题。术后早期并发症的管理可能需要多学科的方法来优化并发症管理的结果,包括外科医生、内窥镜医师和全天候管理患者的病房医生。这种手拉手的方法可以为患者提供最好的治疗,内窥镜检查在解决腔内问题方面发挥着至关重要的作用,比重复的手术干预侵入性小得多,从而大大简化了术后过程。关键信息:手术入路,配合腔内并发症的处理,构成了全面的内脏医学,因为内镜是MBS背景下手术的帮手。
{"title":"Endoscopic Management of Postsurgical Complications after Metabolic and Bariatric Surgery.","authors":"Christine Stier, Sebastian Belle, Patrick Téoule","doi":"10.1159/000546193","DOIUrl":"10.1159/000546193","url":null,"abstract":"<p><strong>Background: </strong>Following metabolic and bariatric surgery (MBS), a wide range of symptoms may indicate postoperative complications, all of which can prompt endoscopic inspection and multidisciplinary management of potential complications. Therefore, an anatomical and technical understanding of the previous surgical procedure and its forms of reconstruction especially after MBS is crucial for the attending endoscopist to optimize endoluminal therapy. A selective literature review has been performed. This overview of endoscopic complication management aims to outline the available options after MBS.</p><p><strong>Summary: </strong>Postoperative complication rates vary widely depending on the antecedent procedure and have been reported to be relevant after specific procedures such as laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass in the context of MBS. There is a timeline of 30 days in the postoperative course that divides early from late complications. While anastomotic leaks or endoluminal bleeding are considered typical early complications, late complications include problems such as strictures and anastomotic ulcers. Management of complications in the immediate postoperative period (very early complications) may require a multidisciplinary approach to optimize the outcome of complication management, involving the surgeon, the endoscopist and the ward physician who manages the patient round-the-clock. This hand-in-hand approach enables the best possible treatment for the patient, with endoscopy playing a crucial role in solving endoluminal problems in a much less invasive way than repeated surgical intervention, thereby contributing significantly to an easier postoperative course.</p><p><strong>Key messages: </strong>The surgical approach, in cooperation with endoluminal complication management, constitutes comprehensive visceral medicine, as endoscopy is the helping hand of surgery in the context of MBS.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-15"},"PeriodicalIF":1.8,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12185107/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144487237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Visceral Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1